Skip to content

Comparison of Semitendinosus and Quadriceps Grafts for Anterior Cruciate Ligament Reconstruction

Examining Anterior Cruciate Ligament Reconstruction With Quadriceps- vs. Semitendinosus Tendon Graft for Young Federated Male Football Players.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06167343
Enrollment
54
Registered
2023-12-12
Start date
2023-10-01
Completion date
2025-12-20
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL, ACL Injury

Brief summary

To investigate the differences between the two methods for reconstruction of the anterior cruciate ligament (ACL), to support the development of the best method for young federated male football players. After surgery with quadricipital tendon graft or semitendinosus tendon graft, a two-year follow-up and the rate of return to sport are proposed.

Detailed description

The anterior cruciate ligament is one of the most common traumatic injuries in football, and surgery is proposed to restore knee stability. However, following surgery, few studies have focused on functional recovery of the knee with a wide arsenal of physical tests. Therefore, this study aims to study the efficacy for young football players of two types of grafts based on the most common tendons, the quadricipital and the semitendinosus (without the semimembranosus). Follow-ups will be performed at three months, six months, one year and two years after reconstruction. The variables measured will be isokinetic strength of flexors and extensors, unipodal jump test, self-perceived function, pain and tendon architecture with ultrasound.

Interventions

PROCEDUREACL reconstruction

In addition to surgical reconstruction, any structures that may have been injured concomitantly (meniscus, other ligament) will be repaired in the same surgery.

Sponsors

Universidad de Granada
Lead SponsorOTHER
Hospital Vithas
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
14 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed anterior cruciate ligament rupture by MRI. * Prognosis of anterior cruciate ligament reconstruction surgery. * Be a registered or recreational football player.

Exclusion criteria

* Previous knee surgery. * Having articular cartilage lesions of Outerbridge grade greater than III-IV.

Design outcomes

Primary

MeasureTime frameDescription
Lower limb strengthParticipants will be followed over 24 monthsassessed by an isokinetic test with an isokinetic dynamometer (HUMAC NORM)
Horizontal hop testParticipants will be followed over 24 monthsassessed by horizontal jump with one leg and hands on the waist, measured with a centimetric tape (three jumping opportunities)

Secondary

MeasureTime frameDescription
Self-reported functionalityParticipants will be followed over 24 monthsassessed by Tegner Lysholm Knee Scoring Scale and Modified Cincinnati Rating System Questionnaire (Spanish version)
Knee painParticipants will be followed over 24 monthsassessed by Visual Analogue Scale (VAS) for knee pain. The subjective perception of pain from 0 to 10 will be registered. Higher scores mean a worse outcome.
Pressure pain thresholdParticipants will be followed over 24 monthsUsing a digital algometer in epicondyle, vastus lateralis, vastus medialis and quadricipitalis tendon, patellar tendon, and insertion of the semitendinous tendon
Tendon ultrasoundParticipants will be followed over 24 monthsit will monitor the morphology of the tendon and their surgical gap using ultrasound (Samsung HM70A echograph and Samsung Phased Array PE2-4 probe)
PerimetersParticipants will be followed over 24 monthsmeasured with the volume of both legs (injured and uninjured) using the mid-thigh circumference.

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORManuel Arroyo-Morales, PhD PT, MD

Universidad de Granada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026